Nirved Chemicals Private Limited
Founded in 2021 and headquartered in Gujarat, India.
2021 | Vadodara, Gujarat (India) | Active
Nirved Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 10.00 K
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.08 Cr
About Nirved Chemicals
Nirved Chemicals Private Limited (NCPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2021 (Three years and five months 13 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 10.00 K .
The company currently has active open charges totaling ₹1.08 Cr.
Pankaj Singh and Madan Singh serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33100GJ2021PTC125642
- Company No.
125642
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2021
- Date of AGM
17 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Healthcare
Who are the key members and board of directors at Nirved Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Singh  | Director | 16-Sep-2021 | Current |
| Madan Singh | Director | 16-Sep-2021 | Current |
Financial Performance of Nirved Chemicals.
Enhance accessibility to Nirved Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nirved Chemicals?
Unlock access to Nirved Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹10.80 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 1.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2024 | Uco Bank | ₹1.08 Cr | Open |
How Many Employees Work at Nirved Chemicals?
Nirved Chemicals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirved Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirved Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.